Full-Time

Associate Territory Manager

Floater

Biote

Biote

201-500 employees

Clinically validated hormone optimization and treatment

No salary listed

Irving, TX, USA

In Person

Temporary location assignments within defined territories; potential relocation after 3-6 months.

Bachelor's

Category
Sales & Account Management (1)
Required Skills
Sales
Cold Calling

Get referred to Biote

See people who can refer or advise you

Requirements
  • Bachelor’s degree is required
  • Concentration in Marketing, Business, Health Sciences, or Communication is preferred
  • Must possess a valid driver’s license with a good driving record
  • Ability to travel to conduct in-person visits and willingness to temporarily be assigned locations within a defined area
  • Ability to adhere to company policies and industry regulations especially in relation to compliance
  • Excellent communication and interpersonal skills with the ability to work effectively within a team environment
  • Ability to make effective and persuasive communications and presentations to physicians, office management, and office staff
  • Ability to understand and communicate the attributes and qualities of Biote products
Responsibilities
  • Meet (or exceed) applicable sales and growth targets
  • Recruit new physicians and other practitioners by prospecting (e.g. cold calling, email outreach, referrals, etc.), conducting virtual and in-person presentations, and closing sales
  • Deliver and facilitate presentations to new and established providers to further promote Biote services and products
  • Provide sales support to existing Biote providers within assigned markets/territories
  • Build relationships with provider offices in multiple markets within defined territories
  • Acquire and retain knowledge of hormone replacement therapy, Biote products and processes, and sales approaches through company provided materials, trainings, and real-world experiences
  • Maintain existing Biote accounts by completing business reviews, facilitating staff trainings, conducting basic education programs, and cross-selling, etc.
  • Maintain accurate records of contacts, activities, opportunities, and forecasts within the company’s CRM system
  • Collaborate with the assigned Region Manager, Clinical Education, Marketing, and Operations teams to coordinate trainings, patient education seminars, and local events
  • Respond to inquiries received from customers, Biote employees, and related vendors in a timely manner
  • Perform other related duties, as assigned
Desired Qualifications
  • Concentration in Marketing, Business, Health Sciences, or Communication is preferred
  • Previous sales experience or participation in a secondary education sales program or sales competition is preferred

Biote focuses on hormone optimization using clinically validated medical approaches to identify and treat imbalances in hormone production. It uses lab testing and medical assessment to pinpoint hormone deficiencies or excesses, then prescribes personalized treatment plans—often including bio-identical hormone therapy and related regimens—under medical supervision to restore balanced hormone levels. Biote differentiates itself through its emphasis on translating extensive scientific insight (80+ years of research) into validated protocols and continuing medical oversight, rather than generic supplements. The company’s goal is to help patients achieve balanced hormone levels and improve health outcomes by delivering scientifically grounded, physician-guided hormone optimization.

Company Size

201-500

Company Stage

IPO

Headquarters

Irving, Texas

Founded

2012

Get referred to Biote

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Biote resolved several legal matters in Q2 2026, reducing future SG&A drag.
  • Komal Bajaj became Chief Medical Officer on June 1, 2026, strengthening clinical credibility.
  • Asteria normalized inventory in August 2026, supporting second-half 2026 recovery and guidance rebound.

What critics are saying

  • The January 2026 Asteria recall cut Q2 2026 revenue 9.5% and margin.
  • Bret Christensen’s June 8, 2026 exit and Bob Peterson’s interim CEO role signal instability.
  • Biote’s SEC 10-K flags regulatory pressure on compounded hormones and Nasdaq delisting risk.

What makes Biote unique

  • Biote’s practitioner network and training model create sticky clinic relationships and repeat utilization.
  • Asteria Health gives Biote proprietary pellet manufacturing control, despite the January 2026 recall.
  • Biote pairs pellets with supplements, creating cross-sell revenue beyond procedures.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Paid Time Off

Company News

Hemingway Medical Spa
Jan 11th, 2025
Testosterone and Estradiol Pellet Therapy: Unlocking Wellness with Bioidentical Hormone Pellets

Hemingway Medical Spa Inc. partnered with Biote because they share its commitment to improving the quality of patients lives through a more natural and less pharmacologic approach.

Hampton Roads Orthopaedics Spine & Sports Medicine
Mar 1st, 2024
Transform Your Well-being with Bioidentical Hormone Replacement Therapy

Hampton Roads Orthopaedics and Sports Medicine has chosen Biote as its partner for hormone replacement therapy due to their proven track record and commitment to excellence.

Dallas Next
Jan 24th, 2024
Biote Acquires Asteria Health for $8.5M, Names New CFO

Irving-based Biote Corp. announced that it will acquire Asteria Health, a privately held manufacturer of compounded bioidentical hormones, in a deal valued at $8.5 million.

Business Wire
Jan 18th, 2024
Biote to Purchase Asteria Health

biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hor

Read Magazine
Jan 12th, 2024
Biote Names Robert Peterson as Chief Financial Officer

biote Corp., a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, announced that Robert Peterson has been named Chief Financial Officer, effective January 8, 2024.